Publication|Articles|September 19, 2025
- Pharmaceutical Executive: September 2025
- Volume 45
- Issue 7
Pharmaceutical Executive: September 2025 Interactive Digital Edition
View the Pharmaceutical Executive September 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
21 days ago
Can AI Point the Way?22 days ago
Turning AI Pilots into Enterprise Value23 days ago
Paul Hudson: A Mindset for Miracles23 days ago
How AI is Shaping KOL and DOL Identification25 days ago
Measuring the ROI of SPP Adherence ProgramsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
2
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
3
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
4
The Situation We Faced: The Development and Commercialization of MariTide
5